Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Texas Md Anderson Cancer Center
Headquarters: Houston, TX, United States of America
Website: http://www.mdanderson.org
Year Founded: 1941
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 1, 2025
Distillery Therapeutics
Conditional NRF2 activator for oxidative stress disorders
BioCentury | Mar 12, 2025
Discovery & Translation
Science Spotlight: Killing the mesenchymal precursors that drive cancer progression
BioCentury’s roundup of translational innovations also includes blood detection of pregnancy complications, BBB-crossing antibodies, and more
BioCentury | Oct 25, 2024
Finance
Why Rice is launching a venture studio in Houston’s emerging biotech ecosystem
Founders see chance to build start-ups from university IP, with clinical infrastructure already in place from local institutions
BioCentury | Oct 10, 2024
Discovery & Translation
Science Spotlight: As miRNAs get Nobel Prize, targeting advances continue
BioCentury’s roundup of translational innovation also features Vedanta’s solution to GI infection, Takeda’s exon-skipping delivery tech, and more
BioCentury | Sep 27, 2024
Discovery & Translation
Three tensions in early-stage translation: BioCentury Grand Rounds
Across disciplines, researchers are navigating trade-offs in advancing translation that boil down to scope versus focus
BioCentury | Aug 30, 2024
Discovery & Translation
Science Spotlight: Roche’s intestinal immuno-organoids, cytokine METRNL’s role in tumors, and more
BioCentury’s roundup of translational innovations
BioCentury | Aug 8, 2024
Discovery & Translation
Science Spotlight: Stopping herpes from entering neurons, tissue-specific nanoparticles, and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 633